Literature DB >> 30113398

Comparative Regimens of Lipid Rescue From Bupivacaine-Induced Asystole in a Rat Model.

Le Liu1, Zhousheng Jin1, Xixi Cai1, Yun Xia2, Meiling Zhang3, Thomas J Papadimos4, Xuzhong Xu1, Kejian Shi1.   

Abstract

BACKGROUND: It is currently unknown whether bupivacaine-induced asystole is better resuscitated with lipid emulsion (LE) administered peripherally or centrally, and whether different LE regimens administered peripherally demonstrated similar effects. In this study, we compared the effects of various regimens of lipid administration in a rat model of bupivacaine-induced asystole.
METHODS: Forty-five adult male Sprague-Dawley rats were subjected to bupivacaine-induced asystole and randomly divided into 3 lipid regimens groups: (1) 20% LE was administered continuously via the internal jugular vein (CV-infusion group); (2) 20% LE was administered continuously via the tail vein (PV-infusion group); and (3) 20% LE was administered as divided boluses via the tail vein (PV-bolus group). The maximum dose of LE did not exceed 10 mL·kg(-1). External chest compressions were administered until the return of spontaneous circulation (ROSC) or the end of a 40-minute resuscitation period.
RESULTS: The survival rate, rate of ROSC, systolic blood pressure, heart rate, heart rate-blood pressure product, and coronary perfusion pressure during 2-40 minutes in the CV-infusion and PV-bolus groups were significantly higher than those in the PV-infusion group (P < .01), and the plasma total bupivacaine concentration and myocardial bupivacaine content were significantly lower (P < .05). Time to heartbeat return and time to ROSC in the CV-infusion and PV-bolus groups were significantly shorter than those in the PV-infusion group (P < .05).
CONCLUSIONS: In the rat model of bupivacaine-induced asystole, a divided LE bolus regimen administered peripherally provided a better resuscitation outcome than that of a continuous LE infusion regimen peripherally, and performed in a similar fashion as the continuous LE infusion regimen administered centrally.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30113398     DOI: 10.1213/ANE.0000000000003711

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  Effects of delta-opioid receptor agonist pretreatment on the cardiotoxicity of bupivacaine in rats.

Authors:  Chenran Wang; Shen Sun; Jing Jiao; Xinhua Yu; Shaoqiang Huang
Journal:  BMC Anesthesiol       Date:  2022-01-12       Impact factor: 2.217

2.  The anesthetic bupivacaine induces cardiotoxicity by targeting L-type voltage-dependent calcium channels.

Authors:  YaNan Gao; Bo Chen; Xue Zhang; Rui Yang; QingLi Hua; BaiDong Li
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.